Direct Meds GLP-1 vs Hims: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Direct Meds GLP-1 and Hims tie at 7.9/10 on our rubric, so the decision comes down to price and format rather than overall quality. Full reasoning, pricing and the cases where the other one wins are below.

Visit Direct Meds GLP-1 - our pick of these two →or find your match

Direct Meds GLP-1 and Hims are tied at 7.9/10. Published pricing is not a like-for-like monthly comparison: Direct Meds GLP-1 is from $297/mo; Hims is $188 first month, then $298/mo. Choose Direct Meds GLP-1 for users who value published format-specific pricing and can independently monitor billing and cancellation. Choose Hims for men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership, but should know going in that hims' customer-experience signal is weaker than smaller competitors.

A side-by-side look at Direct Meds GLP-1 and Hims to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Direct Meds GLP-1

#8 of 54

7.9/10

Compounded GLP-1 program with published format-specific prices, offset by a sharply negative BBB complaint record around billing, cancellation, and fulfillment.

Visit Direct Meds GLP-1

Hims

#7 of 54

7.9/10

The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy, Ozempic, Foundayo, and Zepbound paths and has since exited compounded semaglutide for new retail patients. The advertised medication floor is $149, but the required Weight Loss Membership adds $39 in month one and $149/month after that, so the all-in floor is $188 initially and $298 ongoing before any product- or dose-specific increase. Its parent still reports offering access to compounded GLP-1 medications on a limited scale (Q2 2026 results, filed with the SEC August 10, 2026). Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026), significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28%, the highest 1-star rate in our table, clustered around subscription/billing complaints.

Visit Hims

Feature	Direct Meds GLP-1	Hims
Why each one	Thorough clinical consultations focused on medical-grade patient experience rather than quick-turnaround prescribing.	The only publicly-traded men's telehealth (NYSE: HIMS) with FDA-approved Wegovy via direct Novo Nordisk partnership. Brand-name access plus SEC accountability, but balanced against a 3.0 Trustpilot rating that lags peers.
Our Score	7.9/10	7.9/10
Headline Price	from $297/mo	$188 first month, then $298/mo
Medication Type	Compounded	Brand
Insurance Accepted	No	No
Best For	Users who value published format-specific pricing and can independently monitor billing and cancellation	Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitors
Watch out for	Compounded medications only, no brand-name Wegovy, Zepbound, or Ozempic on the menu	Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable.
Ranking	#8	#7
Get started	Visit Direct Meds GLP-1	Visit Hims

Pros & Cons Compared

Direct Meds GLP-1

Pros

+The published $297/mo compounded semaglutide injection tier includes medication, consultations, shipping, and pharmacy fees
+Format-specific prices are published on the site, which makes the advertised medication and service bundle easier to compare
+Fast pharmacy fulfillment: most orders ship within 48 hours of provider approval
+Responsive customer support with live chat available during business hours

Cons

−Compounded medications only, no brand-name Wegovy, Zepbound, or Ozempic on the menu
−The $297/mo injectable semaglutide rate sits above Henry Meds ($199) and TrimRx (starting at $179); Direct Meds' own sublingual semaglutide drops at $179 are the budget path if the premium stings
−BBB shows 248 complaints and roughly 1.1/5 customer-review stars, with recurring reports of unauthorized charges, cancellation difficulty, billing confusion, and unfulfilled or delayed orders

Hims

Pros

+Publicly traded company (NYSE: HIMS), SEC-filed financials, regulatory accountability that private competitors don't have.
+2026 Novo Nordisk partnership, FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
+Medication starts at $149/mo for Wegovy pill, Foundayo, and Ozempic pill; Wegovy or Ozempic pens start at $199 and Zepbound at $299. The required membership makes the lowest all-in path $188 in month one and $298/mo ongoing, and exact product or dose can cost more.
+Polished app and web experience, among the best user interfaces in men's telehealth.
+8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461), significant real-world adoption.

Cons

−Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable.
−Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026), significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
−28% of Trustpilot reviews are 1-star, the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
−Hims reviews span ALL their products (ED, hair loss, mental health, weight loss), not just GLP-1. But the rating still applies because most users don't separate experiences by product.
−'Hims Oral Kit' is NOT a GLP-1, it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Do not confuse its $69 price with the current brand-name GLP-1 menu.
−The $149 GLP-1 figures are medication-only. A required Weight Loss Membership costs $39 in month one and $149/mo ongoing, so a $149 medication path totals at least $188 initially and $298/mo after that.
−Cash-pay only, Hims does not bill insurance, so an insured buyer may do better on a copay.
−Generic high-volume support, large patient base means less personalized attention than smaller competitors.

Our Verdict

Direct Meds GLP-1 and Hims are closely matched with identical scores of 7.9/10. Published pricing is not a like-for-like monthly comparison: Direct Meds GLP-1 is from $297/mo; Hims is $188 first month, then $298/mo.